Volume 10, Issue 5 (10-2012)                   IJRM 2012, 10(5): 477-482 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Dehghani Firouzabadi R, Mohammadian F, Mashayekhy M, Davar R, Eftekhar M. The correlation between follicular fluid pregnancy-associated plasma protein A levels, fertilization, and embryo quality in GnRH agonist and GnRH antagonist protocols in ART cycles. IJRM 2012; 10 (5) :477-482
URL: http://ijrm.ir/article-1-306-en.html
The correlation between follicular fluid pregnancy-associated plasma protein A levels, fertilization, and embryo quality in GnRH agonist and GnRH antagonist protocols in ART cycles
Razieh Dehghani Firouzabadi1 , Farnaz Mohammadian * 2, Mehri Mashayekhy3 , Robab Davar1 , Maryam Eftekhar1
1- Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Department of Obstetrics and Gynecology, Zanjan University of Medical Sciences, Zanjan, Iran , Mohammadian_farnaz@yahoo.com
3- Department of Obstetrics and Gynecology, Arak University of Medical Sciences, Arak, Iran
Abstract:   (2807 Views)
Background: Determination of oocyte fertilization and embryo quality are one of the most important purposes in ART cycles. Follicular fluid provides an important microenvironment for development of oocytes and some biochemical characteristics of the follicular fluid, such as pregnancy-associated plasma protein-A (PAPP-A), may play an important role in prediction of success rate of ART.
Objective: This study was performed to evaluate whether there was any difference in follicular fluid PAPP-A, fertilization, and embryo quality between GnRH agonist long protocol and flexible GnRH antagonist multiple-dose protocol in ART cycles.
Materials and Methods: A total of 100 women who were candidates for ART were enrolled the study and were divided into two groups, GnRH agonist (GnRHa) long protocol (n=51) and flexible GnRH antagonist (GnRHant) multiple-dose protocol (n=49). Follicular fluid sample was obtained from a single mature follicle and follicular fluid PAPP-A level, fertilization and embryo quality of the same oocyte were evaluated in both groups.
Results: There was no significant difference in the mean levels of follicular fluid PAPP-A between the GnRHa protocol and GnRHant protocol (3.5±1.4 vs. 3.8±1.9, respectively). The mean levels of follicular fluid PAPP-A in fertilized oocyte and good quality embryo were comparable in GnRHa and GnRHant protocols.
Conclusion: Our data indicated that no differences of follicular fluid PAPP-A levels were observed between cycles using GnRHa long protocol and those of using flexible GnRHant multiple-dose protocol.
Keywords: Pregnancy-associated plasma protein A, Follicular fluid, GnRH agonist, GnRH antagonist, Assisted reproductive technology
Full-Text [PDF 142 kb]   (593 Downloads) |   |   Full-Text (HTML)  (341 Views)  
Type of Study: Original Article |
References
1. Suh J, Lee E, Hwang S, Yoon S, Yoon B, Bae D, et al. Dose of GnRH agonist (nafarelin acetate) affects intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle. Eur J Obstet Gynecol Reprod Biol 2004;112: 65-68. [DOI:10.1016/S0301-2115(03)00317-8]
2. Choi YS, Ku SY, Jee BC, Suh CS, Choi YM, Kim JG, et al. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients. Hum Reprod 2006; 21: 2015-2021. [DOI:10.1093/humrep/del091]
3. Revelli A, Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009; 7: 40. [DOI:10.1186/1477-7827-7-40]
4. Knight PG, Glister C. TGF-{beta} superfamily members and ovarian follicle development. Reproduction 2006; 132: 191-206. [DOI:10.1530/rep.1.01074]
5. Choi D, Hwang S, Lee E, Park C, Yoon B, Lee J, et al. Recombinant FSH and pregnancy-associated plasma protein. Eur J Obstet Gynecol Reprod Biol 2003; 109: 171-176. [DOI:10.1016/S0301-2115(02)00514-6]
6. Porter R, Smith W, Craft I, Abdulwahid N, Jacobs H. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984; 2: 1284-1285. [DOI:10.1016/S0140-6736(84)92840-X]
7. Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissmann T, et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 1994; 9: 788-791. [DOI:10.1093/oxfordjournals.humrep.a138597]
8. Parinaud J, Beaur A, Bourreau E, Vieitez G, Pontonnier G. Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril 1988; 50: 597-602. [DOI:10.1016/S0015-0282(16)60190-5]
9. Ludwig M, Katalinic A, Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Arch Gynecol Obstet 2001; 265: 175-182. [DOI:10.1007/s00404-001-0267-2]
10. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002; 17: 874-875. [DOI:10.1093/humrep/17.4.874]
11. Aflatoonian A, Mashayekhy M, Mohamadian F, Mansoori Moghaddam M. The correlation between follicular fluid anti-mullerian hormone levels and fertilization and embryo quality in ART cycles. Iran J Reprod Med 2010; 8: 157-160.
12. Leroy JL, Vanholder T, Delanghe JR, Opsomer G, Van Soom A, Bols PE, et al. Metabolic changes in follicular fluid of the dominant follicle in high-yielding dairy cows early post partum. Theriogenology 2004; 62: 1131-1143. [DOI:10.1016/j.theriogenology.2003.12.017]
13. Taymor M. The regulation of follicle growth: some clinical implications in reproductive endocrinology. Fertil Steril 1996; 65: 235-247. [DOI:10.1016/S0015-0282(16)58077-7]
14. Brus L, Lambalk C, De Koning J, Helder M, Janssens R, Schoemaker J. Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles. Hum Reprod 1997; 12: 769-773. [DOI:10.1093/humrep/12.4.769]
15. Raga F, Casan EM, Kruessel J, Wen Y, Bonilla-Musoles F, Polan ML. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 1999; 140: 3705-3712. [DOI:10.1210/endo.140.8.6899]
16. Funston RN, Seidel GE Jr. Gonadotropin-releasing hormone increases cleavage rates of bovine oocytes fertilized in vitro. Biol Reprod 1995; 53: 541-545. [DOI:10.1095/biolreprod53.3.541]
17. Erickson GF, Shimasaki S. The physiology of folliculogenesis: the role of novel growth factors. Fertil Steril 2001; 76: 943-949. [DOI:10.1016/S0015-0282(01)02859-X]
18. Conover CA, Oxvig C, Overgaard MT, Christiansen M, Giudice LC. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. J Clin Endocrinol Metab 1999; 84: 4742-4745. [DOI:10.1210/jcem.84.12.6342]
19. Sudo N, Shimizu T, Kawashima C, Kaneko E, Tetsuka M, Miyamoto A. Insulin-like growth factor-I (IGF-I) system during follicle development in the bovine ovary: relationship among IGF-I, type 1 IGF receptor (IGFR-1) and pregnancy-associated plasma protein-A (PAPP-A). Mol Cell Endocrinol 2007; 264: 197-203. [DOI:10.1016/j.mce.2006.10.011]
20. Moos J, Filova V, Pavelkova J, Moosova M, Peknicova J, Rezabek K. Follicular fluid and serum levels of inhibin A and pregnancy-associated plasma protein A in patients undergoing IVF. Fertil Steril 2009; 91: 1739-1744. [DOI:10.1016/j.fertnstert.2008.01.102]
21. Hourvitz A, Widger AE, Filho FLT, Chang RJ, Adashi EY, Erickson GF. Pregnancy-associated plasma protein-A gene expression in human ovaries is restricted to healthy follicles and corpora lutea. J Clin Endocrinol Metab 2000; 85: 4916-4919. [DOI:10.1210/jcem.85.12.7169]
22. Conover CA, Faessen GF, Ilg KE, Chandrasekher YA, Christiansen M, Overgaard MT, et al. Pregnancy-Associated Plasma Protein-A Is the Insulin-Like Growth Factor Binding Protein-4 Protease Secreted by Human Ovarian Granulosa Cells and Is a Marker of Dominant Follicle Selection and the Corpus Luteum. Endocrinol 2001; 142: 2155-2158. [DOI:10.1210/endo.142.5.8286]
23. Rivera GM, Chandrasekher YA, Evans AC, Giudice LC, Fortune JE. A potential role for insulin-like growth factor binding protein-4 proteolysis in the establishment of ovarian follicular dominance in cattle. Biol Reprod 2001; 65: 102-111. [DOI:10.1095/biolreprod65.1.102]
24. Wang TH, Chang CL, Wu HM, Chiu YM, Chen CK, Wang HS. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril 2006; 86: 1392-1401. [DOI:10.1016/j.fertnstert.2006.03.064]
25. Depa-Martynow M, Jedrzejczak P, Pawelczyk L. Pronuclear scoring as a predictor of embryo quality in in vitro fertilization program. Folia Histochem Cytobiol 2007; 45 (Suppl.): 85-89.
26. Rezabek K, Moosova M, Pavelkova J, Moos J, Filova V. Follicular fluid and serum concentrations of PAPP-A in OHSS risk group of women undergoing IVF stimulation. Ceska Gynekol 2009; 74: 80-84.
27. Stanger JD, Yovich JL, Grudzinskas JG, Bolton AE. Relation between pregnancy-associated plasma protein A (PAPP-A) in human peri-ovulatory follicle fluid and the collection and fertilization of human ova in vitro. Br J Obstet Gynaecol 1985; 92: 786-792. [DOI:10.1111/j.1471-0528.1985.tb03047.x]
28. Hugues JN, Durnerin IC. Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins. Hum Reprod Update 1998; 4: 83-101. [DOI:10.1093/humupd/4.1.83]
29. Racowsky C, Prather AL, Johnson MK, Olvera SP, Gelety TJ. Prematurely condensed chromosomes and meiotic abnormalities in unfertilized human oocytes after ovarian stimulation with and without gonadotropin-releasing hormone agonist. Fertil Steril 1997; 67: 932-938. [DOI:10.1016/S0015-0282(97)81410-0]
30. Selva J, Martin-Pont B, Hugues J, Rince P, Fillion C, Herve F, et al. Cytogenetic study of human oocytes uncleaved after in-vitro fertilization. Hum Reprod 1991; 6: 709-713. [DOI:10.1093/oxfordjournals.humrep.a137413]
31. Wunder DM, Mueller MD, Birkhäuser MH, Bersinger NA. Steroids and protein markers in the follicular fluid as indicators of oocyte quality in patients with and without endometriosis. J Assist Reprod Genet 2005; 22: 257-264. [DOI:10.1007/s10815-005-5149-2]
32. Adashi EY. Insulin-like growth factors as determinants of follicular fate. J Soc Gynecol Invest 1995; 2: 721-726. [DOI:10.1177/107155769500200601]
33. Mason H, Cwyfan-Hughes S, Holly J, Franks S. Potent inhibition of human ovarian steroidogenesis by insulin-like growth factor binding protein-4 (IGFBP-4). J Clin Endocrinol Metab 1998; 83: 284-287. [DOI:10.1210/jcem.83.1.4630]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb